Hedgehog Pathway Inhibitors and Their Utility in Basal Cell Carcinoma: A Comprehensive Review of Current Evidence
Abstract Basal cell carcinoma (BCC) is the most commonly diagnosed malignancy in humans, and as such it poses a significant healthcare burden. The majority of BCC cases are amenable to cure by surgical extirpation. However, until recently there have been no good treatment options for a significant m...
Saved in:
Main Authors: | Evelyn Yu-Xin Tay (Author), Yee-Leng Teoh (Author), Matthew Sze-Wei Yeo (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hedgehog Pathway and Programmed Cell Death Protein-1 Inhibitors for Advanced Basal Cell Carcinoma
by: Babette J.A. Verkouteren, et al.
Published: (2024) -
Update on Hedgehog Pathway Inhibitor Therapy for Patients with Basal Cell Naevus Syndrome or High-frequency Basal Cell Carcinoma
by: Babette J.A. Verkouteren, et al.
Published: (2022) -
Hedgehog signaling pathway and its targets for treatment in basal cell carcinoma
by: Cucchi D, et al.
Published: (2012) -
[Translated article] Vismodegib and Sonidegib in Locally Advanced and Metastatic Basal Cell Carcinoma: Update on Hedgehog Pathway Inhibitors
by: J. Kurnia Wijaya, et al.
Published: (2022) -
Expression of Hedgehog Signaling Pathway Proteins in Basal Cell Carcinoma: Clinicopathologic Study
by: Deng LJ, et al.
Published: (2022)